Related references
Note: Only part of the references are listed.Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs
Hai-Yun Yen et al.
LABORATORY INVESTIGATION (2012)
Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks
Laura M. Williamson et al.
CARCINOGENESIS (2011)
Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone
Sanghoon Lee et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2011)
Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
Ghada N. Farhat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Changes in the Mouse Estrus Cycle in Response to Brca1 Inactivation Suggest a Potential Link between Risk Factors for Familial and Sporadic Ovarian Cancer
Hao Hong et al.
CANCER RESEARCH (2010)
Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oestrogen-mediated phosphorylation and stabilization of BRCA2 protein in breast
J. L. Malone et al.
JOURNAL OF PATHOLOGY (2009)
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status
P. E. Lonning et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women
A. Heather Eliassen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
M Bramley et al.
BRITISH JOURNAL OF CANCER (2006)
Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression
YF Hu et al.
ONCOGENE (2005)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The changing global patterns of female breast cancer incidence and mortality
F Bray et al.
BREAST CANCER RESEARCH (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
